Atomic AI

Back to Companies Directory

Atomic AI

Atomic AI logo

Website
https://atomic.ai/

Founded
2020

Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people.

Articles Mentioning This Company

Seven RNA Biotech Companies To Watch in 2026

For many years the focus of therapeutic developments and scientific research was directed at the genome and proteins. Yet, there is a completely different level of cell regulation – transcriptome level, presented by Ribonucleic acids (RNAs). RNA molecules are not just intermediates between DNA and proteins, in fact, they also carry …

17 Companies Pioneering AI Foundation Models in Pharma and Biotech

Foundation models represent a relatively new paradigm in artificial intelligence (AI), revolutionizing how machine learning models are developed and deployed. Foundation models are a class of large-scale machine learning models, typically based on deep learning architectures such as transformers, that are trained on massive datasets encompassing diverse types of data. The …

11 Biopharma Trends to Watch in 2024

2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope of technological and scientific advances is in stark contrast with the overall industry’s economic performance—it was also a rough year for biopharma overall. There are signs that 2024 might be better …